Annual report pursuant to Section 13 and 15(d)

Financing (Details)

v3.21.1
Financing (Details) - USD ($)
shares in Thousands
1 Months Ended 4 Months Ended 12 Months Ended
Oct. 21, 2019
Sep. 18, 2018
Oct. 31, 2019
May 31, 2019
Sep. 23, 2020
Dec. 31, 2020
Dec. 31, 2019
Jul. 31, 2020
Debt Instrument [Line Items]                
Principal payments on advance           $ 350,000 $ 892,000  
Issuance of common stock, conversions and exchanges (shares)       51     174  
Issuance of common stock, conversions and exchanges           1,577,000 $ 962,000  
Loss on extinguishment of debt           $ 119,000 $ 256,000  
Redemption, upon three business days' notice                
Debt Instrument [Line Items]                
Debt instrument term     6 months          
Common Stock                
Debt Instrument [Line Items]                
Issuance of common stock, conversions and exchanges (shares)           399 225  
NDX | Credit Agreement                
Debt Instrument [Line Items]                
Advance from NovellusDx, Ltd.   $ 1,500,000            
Principal payments on advance $ 100,000   $ 1,000,000.0          
Principal balance     $ 450,000          
Due to affiliate               $ 50,000
Stated interest rate     0.00%          
Atlas Sciences                
Debt Instrument [Line Items]                
Stated interest rate 10.00%              
Term note, principal balance $ 1,300,000              
Proceeds unsecured debt 1,300,000              
Unamortized discount 88,000           $ 64,000  
Interest expense 10,000              
Debt instrument term     12 months          
Maximum monthly redemption $ 300,000              
Maximum interest rate upon default 22.00%              
Increase to outstanding balance upon default 15.00%              
Long-term debt           $ 0 1,300,000  
Debt issuance costs, net             $ 7,000  
Atlas Sciences | Common Stock                
Debt Instrument [Line Items]                
Issuance of common stock, conversions and exchanges (shares)         399      
Issuance of common stock, conversions and exchanges         $ 1,600,000